Global private equity and venture capital news and research

Ironbridge’s Monash IVF rises in ASX debut

26 Jun 2014

in vitroPrivate equity-backed Australian in vitro fertilisation company Monash IVF Group surged in its stock market debut.

Shares in Monash closed at A$1.9 compared with the IPO price of A$1.85m. The company, which is backed by private equity firm Ironbridge, raised A$316m ($297m). The private equity firm was expected to sell an 11 per cent interest in the IPO.

Monash, which claims to have completed the first IVF pregnancy in 1973, set the indicative price range at A$1.65 to A$1.95 per share and narrowed it to between A$1.80 and A$1.90 earlier this month.

Meanwhile, another private equity-backed Australian business, toilet paper and tissue maker Asaleo Care, is set to start trading on the Australian Securities Exchange tomorrow.

Asaleo has reportedly priced its IPO at A$1.65 per share, which is in the middle of its indicative range of A$1.55 to A$1.80 per share.

Private equity firm Pacific Equity Partners plans to fully exit it stake in the company via the IPO.

Copyright © 2014 AltAssets

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016